Raymond James Downgrades NGM Biopharmaceuticals (NGM) to Market Perform ‘Due to Possible Going Private Transaction’

Visit StreetInsider.com at http://www.streetinsider.com/Downgrades/Raymond+James+Downgrades+NGM+Biopharmaceuticals+%28NGM%29+to+Market+Perform+%27Due+to+Possible+Going+Private+Transaction%27/22915763.html for the full story.